Dr Catia Marzolini obtained a degree in Pharmacy followed by a PhD in Clinical Pharmacology at the University of Lausanne, Switzerland. She completed a post-doctoral fellowship in the pharmacogenetics of drug transporters within the Division of Clinical Pharmacology at Vanderbilt University, Nashville, USA. She obtained subsequently the “venia docenti” from the University of Basel.

Catia Marzolini is currently working as a senior research scientist in the Division of Infectious Diseases & Hospital Epidemiology at the University Hospital of Basel. Her research focuses on pharmacological and genetic determinants of antiretroviral drug response and toxicity. Catia Marzolini has become an expert in the field of HIV drug-drug interactions. She is a member of the Liverpool HIV drug-drug interactions website and is notably in charge of predicting drug-drug interactions. Catia Marzolini has also joined the European AIDS Clinical Society (EACS) guidelines committee panel for the pharmacological aspects of HIV therapy.